Yahoo · Sep 23, 2026
Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
Despite selling over 9,000 shares, the insider still holds 307,372 shares.
OM
NASDAQ · OMDA
Omada Health
Healthcare · Medical - Healthcare Information Services
$20.89
Up+$0.16 (+0.77%)
Updated Oct 8, 2026, 7:53 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 891.49M
- P/E ratio
- -37.65
- Dividend yield
- 0.00%
- 52-week range
- $10.28 – $26.92
- Volume
- 1.26M
- Avg. volume
- 693.59K
Price performance · OMDA
OMDA price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
OMDA closed at $20.89 after 21 trading sessions, down 2.84% for the selected period.
- Last close
- $20.89
- Period change
- -2.84%
- Period low
- $19.37
- Period high
- $21.50
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $20.70 | $21.40 | $20.65 | $20.89 | 1.26M |
| Oct 6, 2026 | $21.11 | $21.44 | $20.16 | $20.73 | 855.85K |
| Oct 5, 2026 | $20.44 | $21.08 | $20.07 | $20.95 | 747.08K |
| Oct 2, 2026 | $20.74 | $20.98 | $20.32 | $20.37 | 1.25M |
| Oct 1, 2026 | $20.90 | $21.08 | $20.08 | $20.41 | 1.44M |
| Sep 30, 2026 | $19.51 | $20.92 | $19.46 | $20.81 | 2.2M |
| Sep 29, 2026 | $19.48 | $19.50 | $18.68 | $19.37 | 1.18M |
| Sep 28, 2026 | $19.60 | $19.602 | $19.18 | $19.39 | 1.76M |
| Sep 25, 2026 | $19.74 | $20.05 | $19.63 | $19.66 | 873.79K |
| Sep 24, 2026 | $20.56 | $20.9501 | $19.64 | $19.72 | 962.54K |
| Sep 23, 2026 | $21.21 | $21.3792 | $20.42 | $20.69 | 713.09K |
| Sep 22, 2026 | $20.86 | $21.52 | $20.18 | $21.37 | 1.32M |
| Sep 21, 2026 | $20.42 | $20.73 | $20.12 | $20.61 | 791.55K |
| Sep 18, 2026 | $19.80 | $20.74 | $19.64 | $20.43 | 6.71M |
| Sep 17, 2026 | $20.00 | $20.325 | $19.79 | $19.83 | 1.32M |
| Sep 16, 2026 | $19.65 | $20.105 | $19.54 | $19.76 | 887.02K |
| Sep 15, 2026 | $20.24 | $20.68 | $19.63 | $19.67 | 1.66M |
| Sep 14, 2026 | $19.95 | $21.095 | $19.94 | $20.50 | 996.97K |
| Sep 11, 2026 | $21.73 | $21.73 | $19.31 | $19.66 | 1.65M |
| Sep 10, 2026 | $21.27 | $22.79 | $21.20 | $21.50 | 1.16M |
| Sep 9, 2026 | $22.02 | $22.11 | $21.40 | $21.50 | 1.62M |
Latest OMDA news
The latest Smart Investors Daily articles mentioning OMDA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
OMDA research
Overview
Company profile and research snapshot.
Company profile
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $24.67
- Implied upside
- —
- Analysts
- 16
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | Freedom Capital Markets | Buy | — |
| Sep 11, 2026 | Barclays | Overweight | — |
| Sep 11, 2026 | Needham | Buy | — |
| Sep 11, 2026 | BTIG | Buy | — |
| Aug 14, 2026 | JP Morgan | Overweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 11, 2026
Barclays Maintains Overweight on Omada Health, Raises Price Target to $27
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $25 to $27.
Benzinga · Sep 11, 2026
Needham Reiterates Buy on Omada Health, Maintains $28 Price Target
Needham analyst Ryan MacDonald reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $28 price target.
Benzinga · Sep 11, 2026
BTIG Reiterates Buy on Omada Health, Maintains $35 Price Target
BTIG analyst David Larsen reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $35 price target.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
